View Rule

View EO 12866 Meetings

Printer-Friendly Version Download RIN Data in XML

HHS/SAMHSA

RIN: 0930-AA12

Publication ID: Spring 2009

Title: Mandatory Guidelines for the Federal Workplace Drug Testing Program
Abstract: This Final Notice addressed the collection and testing of urine specimens, the requirements for the certification of Instrumented Initial Test Facilities (IITFs), and the role of and standards for collectors and Medical Review Officers (MROs). Additional notices of Proposed Revisions to the Mandatory Guidelines addressing the use of point of collection testing (POCT), oral fluid testing, sweat patch testing, hair testing, and associated issues will be published at a later date. With regard to the use of alternative specimens including hair, oral fluid, and sweat patch specimens in Federal Workplace Drug Testing Programs, significant issues have been raised by Federal agencies during the review process which require further examination, and may require additional study and analysis. As part of the review process for these alternative tests, the Department plans to issue a notice in the Federal Register requesting information and assistance from the general public to provide or identify data and research findings that address specific areas of interest.
Agency: Department of Health and Human Services(HHS)	Priority: Other Significant
RIN Status: Previously published in the Unified Agenda	Agenda Stage of Rulemaking: Completed Actions
Major: No	Unfunded Mandates: No
CFR Citation: None (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: PL 100-71 5 USC 7301

Legal Deadline:

Action	Source	Description	Date
NPRM	Statutory		12/00/2003

Timetable:

Action	Date	FR Cite
Notice	04/13/2004	69 FR 19673
Final Action	11/25/2008	73 FR 71858
Correction	12/10/2008	73 FR 75122

Regulatory Flexibility Analysis Required: No	Government Levels Affected: Federal
Small Entities Affected: No	Federalism: No
Included in the Regulatory Plan: No
RIN Data Printed in the FR: No
Agency Contact: Joseph Denis Faha Director, DLEA, SAMHSA Department of Health and Human Services Substance Abuse and Mental Health Services Administration Room 12C-15, 5600 Fishers Lane, Rockville, MD 20857 Phone:301 443-7017 Fax:301 443-1450 Email: jfaha@samhsa.gov